SCLC accounts for about 12% of all lung cancer cases in the United States, and the disease is fairly aggressive, with a 9% five-year relative survival rate according to the latest data. “Most patients ...

The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber ...

Higher thymic health is linked to better outcomes with immunotherapy in various cancer types. AI-driven CT scan analysis can track thymic health and indicate immune function. Assessing thymic health ...

The Food and Drug Administration (FDA) has granted marketing authorization for the first cryotherapy treatment for older women with early-stage, low-risk breast cancer. Cryoablation, which destroys ...

Anxiety about scans, bloodwork and similar tests is a common experience for many people living with and beyond cancer, but they are finding creative ways to ease its grip.

The average person takes almost 22,000 breaths each day, but most of us don’t breathe properly. This can become a serious issue for people living with cancer and other chronic conditions who have ...

Drugs like Wegovy and Zepbound were associated with a 17% lower risk of cancer overall for people with obesity, with greater reductions for specific malignancies.

Low-grade intermediate-risk non-muscle-invasive bladder cancer (LG-IR-NMIBC) affects around 82,000 people in the United States each year, about 59,000 of whom experience recurrence. The standard ...

Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

People who used GLP-1 receptor agonists like Ozempic had a modestly lower risk for obesity-related malignancies, especially colon and rectal cancer.

Since 2011, Orwig’s team has frozen samples from about 1,000 prepubertal boys, according to the AP. Although the testicular tissues do not yet produce sperm due to their immaturity, they produce stem ...

The FDA initially approved Enhertu in December 2019 for inoperable or metastatic breast cancer with high HER2 expression. Approval was extended to patients with HER2-low breast cancer in August 2022, ...